Abstract:We thank our colleagues for their constructive comments that relate to our two articles in the July 2017 issue of BJSM.
Bermon and Garnier StudyThe main criticisms expressed about the data used and our statistical analysis were (1) our 'concentration' on free testosterone (fT) rather than total testosterone (T) 3 (presumably because the T results were only presented in the Internet version of the paper), (2) the fact that 17.3% of the athletes were sampled at both World Championships (Daegu and Moscow), 3 (… Show more
“…In 2015, the regulations were challenged by an athlete in the Court of Arbitration of Sport (CAS), which then suspended them pending further scientific evidence concerning the influence of testosterone levels in the male range on the athletic performance of women. In response, recent observational data (58,59,60), as well as our RCT described, (55) have provided additional evidence for the performance-enhancing effects of testosterone in female athletes.…”
Section: Regulations Concerning the Eligibility To Compete As A Womanmentioning
confidence: 62%
“…One earlier report including female athletes (n = 22) demonstrated that serum levels of testosterone at rest were positively correlated with explosive performance (the vertical jump test) (57). A much larger study involved more than a 1000 elite female participants in the 2011 and 2013 International Association of Athletics Federations (IAAF) World Championships (58,59), of whom only 1.8% had clearly elevated levels of testosterone indicative of DSD or doping. These athletes were classified in tertiles on the basis of their levels of testosterone, and the performance in those in the highest tertile in the 400-m race, 400-m hurdles and 800-m race was found to be 2.1-2.5% better than that of those in the lowest tertile.…”
Section: The Influence Of Endogenous Androgens On the Physical Performentioning
Emerging evidence indicates that testosterone, which can increase muscle mass and strength, stimulates erythropoiesis, promotes competitive behaviour, and enhances the physical performance of women. Indeed, the levels of testosterone within the normal female range are related to muscle mass and athletic performance in female athletes. Furthermore, among these athletes, the prevalence of hyperandrogenic conditions, including both polycystic ovary syndrome and rare differences/disorders of sex development (DSD), which may greatly increase testosterone production, are elevated. Thus, if the androgen receptors of an individual with XY DSD are functional, her muscle mass will develop like that of a man. These findings have led to the proposal that essential hyperandrogenism is beneficial for athletic performance and plays a role in the choice by women to compete in athletic activities. Moreover, a recent randomized controlled trial demonstrated a significant increase in the lean mass and aerobic performance by young exercising women when their testosterone levels were enhanced moderately. Circulating testosterone is considered the strongest factor to explain the male advantage in sport performance, ranging between 10 and 20%. It appears to be unfair to allow female athletes with endogenous testosterone levels in the male range (i.e. 10–20 times higher than normal) to compete against those with normal female androgen levels. In 2012, this consideration led international organizations to establish eligibility regulations for the female classification in order to ensure fair and meaningful competition, but the regulations are controversial and have been challenged in court.
“…In 2015, the regulations were challenged by an athlete in the Court of Arbitration of Sport (CAS), which then suspended them pending further scientific evidence concerning the influence of testosterone levels in the male range on the athletic performance of women. In response, recent observational data (58,59,60), as well as our RCT described, (55) have provided additional evidence for the performance-enhancing effects of testosterone in female athletes.…”
Section: Regulations Concerning the Eligibility To Compete As A Womanmentioning
confidence: 62%
“…One earlier report including female athletes (n = 22) demonstrated that serum levels of testosterone at rest were positively correlated with explosive performance (the vertical jump test) (57). A much larger study involved more than a 1000 elite female participants in the 2011 and 2013 International Association of Athletics Federations (IAAF) World Championships (58,59), of whom only 1.8% had clearly elevated levels of testosterone indicative of DSD or doping. These athletes were classified in tertiles on the basis of their levels of testosterone, and the performance in those in the highest tertile in the 400-m race, 400-m hurdles and 800-m race was found to be 2.1-2.5% better than that of those in the lowest tertile.…”
Section: The Influence Of Endogenous Androgens On the Physical Performentioning
Emerging evidence indicates that testosterone, which can increase muscle mass and strength, stimulates erythropoiesis, promotes competitive behaviour, and enhances the physical performance of women. Indeed, the levels of testosterone within the normal female range are related to muscle mass and athletic performance in female athletes. Furthermore, among these athletes, the prevalence of hyperandrogenic conditions, including both polycystic ovary syndrome and rare differences/disorders of sex development (DSD), which may greatly increase testosterone production, are elevated. Thus, if the androgen receptors of an individual with XY DSD are functional, her muscle mass will develop like that of a man. These findings have led to the proposal that essential hyperandrogenism is beneficial for athletic performance and plays a role in the choice by women to compete in athletic activities. Moreover, a recent randomized controlled trial demonstrated a significant increase in the lean mass and aerobic performance by young exercising women when their testosterone levels were enhanced moderately. Circulating testosterone is considered the strongest factor to explain the male advantage in sport performance, ranging between 10 and 20%. It appears to be unfair to allow female athletes with endogenous testosterone levels in the male range (i.e. 10–20 times higher than normal) to compete against those with normal female androgen levels. In 2012, this consideration led international organizations to establish eligibility regulations for the female classification in order to ensure fair and meaningful competition, but the regulations are controversial and have been challenged in court.
“…Following the release of a subset of those data, the independent researchers calculated errors in the data ranging from 17-33 per cent for four of the regulated events (400m, 400H, 800m, and 1500m) and called for the study to be retracted (Pielke 2018;Longman 2018). Days before the independent researchers submitted their re-analysis, Bermon and colleagues released their own re-analysis of the data (Pielke 2018;Bermon et al 2018). performance advantage^when it is between 5 and 10 nmol/L (IAAF 2018c, 5).…”
In April 2018, the International Association of Athletics Federations (IAAF) released new regulations placing a ceiling on women athletes' natural testosterone levels to "ensure fair and meaningful competition." The regulations revise previous ones with the same intent. They require women with higher natural levels of testosterone and androgen sensitivity who compete in a set of "restricted" events to lower their testosterone levels to below a designated threshold. If they do not lower their testosterone, women may compete in the male category, in an intersex category, at the national level, or in unrestricted events. Women may also challenge the regulation, whether or not they have lowered their testosterone, or quit sport. Irrespective of IAAF's stated aims, the options forced by the new regulations are impossible choices. They violate dignity, threaten privacy, and mete out both suspicion and judgement on the sex and gender identity of the athletes regulated.
“…The IAAF duly commissioned further research (Bermon et al, 2018; Bermon and Garnier, 2017 [16,17]) the results of which were clearly insufficient, even on the IAAF's own interpretation, to convince the CAS that the performance advantage was of the same magnitude as male athletes or significant across all athletic events. Accordingly, the Hyperandrogenism Regulations were dropped and a variation was introduced that was drafted to focus on certain events where the evidence of performance advantage was deemed by the IAAF to be significant.…”
Section: Classification By Sex and Regulation Of Eligibility To Compementioning
confidence: 99%
“…However, from the historical background to the Testosterone Regulations and from the scientific evidence on which the IAAF purports to rely, that does not appear to be the approach that has been taken. For example, in the Bermon and Garnier studies (Bermon et al, 2018; Bermon and Garnier, 2017 [16,17]) on which heavy reliance is placed, the data in relation to male performance differences based on testosterone levels is far less than the female data (the female data is taken from both the Daegu and Moscow IAAF world championships, but the Daegu world championships is not used in relation to male athletes) and there is a fairly blunt conclusion that there is no significant performance difference between the males with low testosterone levels and those with high levels. Since the whole basis of the Testosterone Regulations is that increased testosterone does provide a performance advantage, it seems strange that the IAAF have not sought to explain or investigate this further, especially given that other academic evidence relied on by the IAAF suggests increases in testosterone in healthy adult males increases muscle strength and size in a linear fashion (Auchus, 2018 [9]).…”
Section: The Problem With Integrity Solidarity and Fair Playmentioning
In 2011 the IAAF introduced the Hyperandrogenism Regulations in an attempt to deal with a difficult problem; that of ensuring ‘fair’ competition in female athletics as a result of athletes with differences in sexual development competing against women without such conditions. In 2015, following a challenge to those regulations by Indian athlete, Dutee Chand, The Court of Arbitration for Sport (CAS) considered the merit of the regulations and determined that there was insufficient scientific evidence to justify their imposition. The regulations were suspended by the CAS, until more convincing evidence could be provided (CAS 2014/A/3759 Chand v AFI and IAAF). The IAAF duly commissioned further research (Bermon and Garnier, 2017) and introduced amended regulations (the Eligibility Regulations for Female Classification (the DSD Regulations)). Although not universal, the IAAF has faced significant criticism from several angles about its approach to the problem. In particular, there has been criticism of the value of the scientific research on which the regulations are based (Franklin et al., 2018; Karkazis et al., 2012; Koh et al., 2018; Sőnksen et al., 2018; Tucker, 2017, Pielke, Tucker & Boye 2019) and also from those in the ethical and human rights fields seeking to ensure that the rights of individual athletes are protected (Adair, 2011; Buzuvis, 2016; Koh et al., 2018). In light of such criticism, this paper considers the IAAF’s approach in dealing with the perceived problem and considers its conduct against an objective framework of ‘good sporting governance’ (Geeraert, 2013; Henry and Lee 2004). It is this paper’s contention that the IAAF’s approach to rule creation in this area demonstrates less than ideal governance practice and, in doing so, notes the role of historical, cultural and institutional barriers as well as an over-reliance on insufficiently conclusive scientific evidence to provide a seemingly objective solution to a fundamentally more complex problem.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.